Emerald Cloud Lab

Executive Summary

Emerald Cloud Lab (ECL) is transforming life science R&D by offering a fully automated, remote-controlled laboratory platform that provides 24/7 access to over 200 instrument models through a software interface. By eliminating physical and logistical barriers, ECL enables scientists to design, execute, and analyze experiments from anywhere, accelerating R&D timelines and reducing costs. Founded in 2014 and based in South San Francisco, the company serves the drug delivery and AI/machine learning sectors, positioning itself as a key enabler of digital lab transformation. As private firms seek to streamline operations and enhance reproducibility, ECL’s cloud lab model is gaining traction, though its adoption rate remains tied to industry willingness to shift from traditional wet lab practices.

Upcoming Catalysts (preview)

• Q3 2026Major pharmaceutical partnership for automated drug discovery workflows60% success
• Q4 2026Expansion of instrument library to include next-generation sequencing and cryo-EM70% success
• Q2 2026Series C funding round exceeding $50M to scale operations55% success